Tauons and prions: Infamous cousins?

Journal of Alzheimer's Disease

Volumn 26, Issue 3, 2011, Pages 413-430

  Novak, Petr ^a   Prcina, Michal ^a   Kontsekova, Eva ^a  

^a INSTITUTE OF NEUROIMMUNOLOGY   (Slovakia)

Author keywords

Alzheimer's disease; prions; tauons; tauopathies; truncated tau protein

Indexed keywords

AMYLOID BETA PROTEIN; ISOPROTEIN; PRION PROTEIN; PROTEOME; TAU PROTEIN;

ALZHEIMER DISEASE; BIOACCUMULATION; CONFORMATIONAL TRANSITION; HUMAN; NERVE DEGENERATION; NEUROFILAMENT; NONHUMAN; PATHOGENESIS; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROCESSING; REVIEW;

EID: 80053493442     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110194     Document Type: Review

References (204)

1. Burns A, Zaudig M (2002) Mild cognitive impairment in older people. Lancet 360, 1963-1965.
2. Alzheimer's Disease International (2010)World Alzheimer Report 2010. World Alzheimer Report 2010.pdf, Accessed June 20, 2011
3. Comas-Herrera A, Wittenberg R, Pickard L, Knapp M (2007) Cognitive impairment in older people: future demand for long-term care services and the associated costs. Int J Geriatr Psychiatry 22, 1037-1045.
4. Cupers P, Sautter J, Vanvossel A (2006) European Union research policy and funding for Alzheimer disease. Nat Med 12, 774-775.
5. Mandavilli A (2006) The amyloid code. Nat Med 12, 747-751.
6. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, WisniewskiHM(1986) Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261, 6084-6089.
7. Wischik CM, Novak M, Thogersen HC, Edwards PC, Runswick MJ, Jakes R, Walker JE, Milstein C, Roth M, Klug A (1988) Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A 85, 4506-4510.
8. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259.
9. Giannakopoulos P, Gold G, Kövari E, Gunten A, Imhof A, Bouras C, Hof PR (2006) Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience. Acta Neuropathol 113,1-12.
10. Grinberg LT, Rüb U, Ferretti REL, Nitrini R, Farfel JM, Polichiso L, Gierga K, Jacob-Filho W, Heinsen H (2009) The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset? Neuropathol Appl Neurobiol 35, 406-416.
11. Delacourte A (2008) Tau pathology and neurodegeneration: an obvious but misunderstood link. J Alzheimers Dis 14, 437-440.
12. Braak H, Del Tredici K (2011) The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol 121, 171-181.
13. Squire LR, Stark CEL, Clark RE (2004) The Medial Temporal Lobe.*. Ann Rev Neurosci 27, 279-306.
14. Novak M, Wischik CM, Edwards P, Pannell R, Milstein C (1989) Characterisation of the first monoclonal antibody against the pronase resistant core of the Alzheimer PHF. Prog Clin Biol Res 317, 755-761.
15. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83, 4913-4917.
16. Wang JZ, Grundke-Iqbal I, Iqbal K (1996) Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease. Nat Med 2, 871-875.
17. Ledesma MD, Bonay P, Colaco C, Avila J (1994) Analysis of microtubule-associated protein tau glycation in paired helical filaments. J Biol Chem 269, 21614-21619.
18. Mori H, Kondo J, Ihara Y (1987) Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 235, 1641-1644.
19. Horiguchi T, Uryu K, Giasson BI, Ischiropoulos H, Light- Foot R, Bellmann C, Richter-Landsberg C, Lee VM, Trojanowski JQ (2003) Nitration of tau protein is linked to neurodegeneration in tauopathies. Am J Pathol 163, 1021-1031.
20. Tucholski J, Kuret J, Johnson GV (1999) Tau is modified by tissue transglutaminase in situ: possible functional and metabolic effects of polyamination. J Neurochem 73, 1871-1880.
21. Novak M, Jakes R, Edwards PC, Milstein C, Wischik CM (1991) Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51. Proc Natl Acad Sci U S A 88, 5837-5841.
22. Novak M, Kabat J, Wischik CM (1993) Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J 12, 365-370.
23. Berry RW, Abraha A, Lagalwar S, LaPointe N, Gamblin TC, Cryns VL, Binder LI (2003) Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment. Biochemistry 42, 8325-8331.
24. Alonso AD, Zaidi T, Novak M, Barra HS, Grundke-Iqbal I, Iqbal K (2001) Interaction of tau isoforms with Alzheimer's disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein. J Biol Chem 276, 37967-37973.
25. Rissman RA, Poon WW, Blurton-Jones M, Oddo S, Torp R, Vitek MP, LaFerla FM, Rohn TT, Cotman CW (2004) Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J Clin Invest 114, 121-130.
26. Cho JH, Johnson GV (2004) Glycogen synthase kinase 3 beta induces caspase-cleaved tau aggregation in situ. J Biol Chem 279, 54716-54723.
27. Zilka N, Filipcik P, Koson P, Fialova L, Skrabana R, Zilkova M, Rolkova G, Kontsekova E, Novak M (2006) Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. FEBS Lett 580, 3582-3588.
28. Kovacech B, Skrabana R, Novak M (2010) Transition of tau protein from disordered to misordered in Alzheimer's disease. Neurodegener Dis 7, 24-27.
29. Iqbal K, Delcalonso A, Chen S, Chohan M, Elakkad E, Gong C, Khatoon S, Li B, Liu F, Rahman A (2005) Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 1739, 198-210.
30. Iqbal K, Grundke-Iqbal I (2007) Alzheimer Review Series: Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention. J Cell Mol Med 12, 38-55.
31. Zilka N, Stozicka Z,KovacA, Pilipcinec E, Bugos O, Novak M (2009) Human misfolded truncated tau protein promotes activation of microglia and leukocyte infiltration in the transgenic rat model of tauopathy. J Neuroimmunol 209, 16-25.
32. Jeganathan S, Hascher A, Chinnathambi S, Biernat J, Mandelkow EM, Mandelkow E (2008) Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of tau and generates a pathological (MC-1) conformation. J Biol Chem 283, 32066-32076.
33. Jakes R, Novak M, Davison M, Wischik CM (1991) Identification of 3- and 4-repeat tau isoforms within the PHF in Alzheimer's disease. EMBO J 10, 2725-2729.
34. Uversky VN, Gillespie JR, Fink AL (2000) Why are "natively unfolded" proteins unstructured under physiologic conditions?. Proteins 41, 415-427.
35. Mocanu MM, Nissen A, Eckermann K, Khlistunova I, Biernat J, Drexler D, Petrova O, Schonig K, Bujard H, Mandelkow E, Zhou L, Rune G, Mandelkow EM (2008) The potential forβ-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous tau in inducible mouse models of tauopathy. J Neurosci 28, 737-748.
36. von Bergen M, Barghorn S, Li L, Marx A, Biernat J, Mandelkow EM, Mandelkow E (2001) Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure. J Biol Chem 276, 48165-48174.
37. Uversky VN, Dunker AK (2010) Understanding protein non-folding. Biochim Biophys Acta 1804, 1231-1264.
38. Gong CX, Liu F, Grundke-Iqbal I, Iqbal K (2005) Posttranslational modifications of tau protein in Alzheimer's disease. J Neural Transm 112, 813-838.
39. Kovacech B, Zilka N,NovakM(2009) Newage of neuroproteomics in Alzheimer's disease research. Cell Mol Neurobiol 29, 799-805.
40. Novak M (1994) Truncated tau protein as a new marker for Alzheimer's disease. Acta Virol 38, 173-189.
41. Frost B, Jacks RL, Diamond MI (2009) Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284, 12845-12852.
42. Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, Fraser G, Stalder AK, Beibel M, Staufenbiel M, Jucker M, Goedert M, Tolnay M (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11, 909-913.
43. Probst A, Gotz J,Wiederhold KH, Tolnay M, Mistl C, Jaton AL, Hong M, Ishihara T, Lee VM, Trojanowski JQ, Jakes R, Crowther RA, Spillantini MG, Burki K, Goedert M (2000) Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol 99, 469-481.
44. Kriwacki RW, Hengst L, Tennant L, Reed SI, Wright PE (1996) Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity. Proc Natl Acad Sci U S A 93, 11504-11509
45. Sergeant N, Delacourte A, Buee L (2005) Tau protein as a differential biomarker of tauopathies. Biochim Biophys Acta 1739, 179-197.
46. Adams SJ, DeTure MA, McBride M, Dickson DW, Petrucelli L, Ferreira ST (2010) Three repeat isoforms of tau inhibit assembly of four repeat tau filaments. PLoS ONE 5, e10810.
47. Liu J, Faeder JR, Camacho CJ (2009) Toward a quantitative theory of intrinsically disordered proteins and their function. Proc Natl Acad Sci U S A 106, 19819-19823.
48. Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A (1988) Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc Natl Acad Sci U S A 85, 4051-4055.
49. Kim W, Lee S, Jung C, Ahmed A, Lee G, Hall GF (2010) Interneuronal transfer of human tau between Lamprey central neurons in situ. J Alzheimers Dis 19, 647-664.
50. Alonso AC, Grundke-Iqbal I, Iqbal K (1996) Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 2, 783-787.
51. Brundin P, Li JY, Holton JL, Lindvall O, Revesz T (2008) Research in motion: the enigma of Parkinson's disease pathology spread. Nat Rev Neurosci 9, 741-745.
52. Lee H, Suk J, Bae E, Lee J, Paik S, Lee S (2008) Assembly-dependent endocytosis and clearance of extracellular α-synuclein. Int J Biochem Cell Biol 40, 1835-1849.
53. Ren P-H, Lauckner JE, Kachirskaia I, Heuser JE, Melki R, Kopito RR (2009) Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol 11, 219-225.
54. Duyckaerts C, UchiharaT, Seilhean D,HeY,HauwJJ (1997) Dissociation of Alzheimer type pathology in a disconnected piece of cortex. Acta Neuropathol 93, 501-507.
55. Mohedano-Moriano A, Pro-Sistiaga P, Arroyo-Jimenez MM, Artacho-Pérula E, Insausti AM, Marcos P, Cebada- Sánchez S, Martínez-Ruiz J, Muñoz M, Blaizot X, Martinez-Marcos A, Amaral DG, Insausti R (2007) Topographical and laminar distribution of cortical input to the monkey entorhinal cortex. J Anat 211, 250-260.
56. Braak H, de Vos RA, Jansen EN, Bratzke H, Braak E (1998) Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. Prog Brain Res 117, 267-285.
57. Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87, 554-567.
58. Frost B, Ollesch J, Wille H, Diamond MI (2009) Conformational diversity of wild-type Tau fibrils specified by templated conformation change. J Biol Chem 284, 3546-3551.
59. Walker L, Levineiii H, Mattson M, Jucker M (2006) Inducible proteopathies. Trends Neurosci 29, 438-443.
60. Braak H, Rub U, Schultz C, Del Tredici K (2006) Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases. J Alzheimers Dis 9, 35-44.
61. Esiri MM, Chance SA (2006) Vulnerability to Alzheimer's pathology in neocortex: the roles of plasticity and columnar organization. J Alzheimers Dis 9, 79-89.
62. Krammer C, Schatzl HM, Vorberg I (2009) Prion-like propagation of cytosolic protein aggregates: insights from cell culture models. Prion 3, 206-212.
63. Pittenger C, Duman RS (2008) Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33, 88-109.
64. Morawski M, Bruckner G, Jager C, Seeger G, Arendt T (2010) Neurons associated with aggrecan-based perineuronal nets are protected against tau pathology in subcortical regions in Alzheimer's disease. Neuroscience 169, 1347-1363.
65. Nishimura M, Tomimoto H, Suenaga T, Namba Y, Ikeda K, Akiguchi I, Kimura J (1995) Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain. Am J Pathol 146, 1052-1058.
66. Espinoza M, de Silva R, Dickson DW, Davies P (2008) Differential incorporation of tau isoforms in Alzheimer's disease. J Alzheimers Dis 14, 1-16.
67. Prusiner SB (1998) Prions. Proc Natl Acad Sci U S A 95,13363-13383.
68. Dunker A, Silman I, Uversky V, Sussman J (2008) Function and structure of inherently disordered proteins. Curr Opin Struct Biol 18, 756-764.
69. Gsponer J, Futschik ME, Teichmann SA, Babu MM (2008) Tight regulation of unstructured proteins: from transcript synthesis to protein degradation. Science 322, 1365-1368.
70. KopitoRR(2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10, 524-530.
71. David DC, Layfield R, Serpell L, Narain Y, Goedert M, Spillantini MG (2002) Proteasomal degradation of tau protein. J Neurochem 83, 176-185.
72. Balch WE, Morimoto RI, Dillin A, Kelly JW (2008) Adapting proteostasis for disease intervention. Science 319, 916-919.
73. Balin BJ, Little CS, Hammond CJ, Appelt DM, Whittum- Hudson JA, Gerard HC, Hudson AP (2008) Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease. J Alzheimers Dis 13, 371-380.
74. Itzhaki RF, Wozniak MA (2008) Herpes simplex virus type 1 in Alzheimer's disease: the enemy within. J Alzheimers Dis 13, 393-405.
75. Kotzbauer P (2004) Fibrillization of α-synuclein and tau in familial Parkinson's disease caused by the A53Tα- synuclein mutation. Exp Neurol 187, 279-288.
76. Lisman JE, Grace AA (2005) The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron 46, 703-713.
77. Lasagna-Reeves CA, Castillo-Carranza DL, Guerrero-Muoz MJ, Jackson GR, Kayed R (2010) Preparation and characterization of neurotoxic tau oligomers. Biochemistry 49, 10039-10041.
78. Morales R, Estrada LD, Diaz-Espinoza R, Morales- Scheihing D, Jara MC, Castilla J, Soto C (2010) Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases. J Neurosci 30, 4528-4535.
79. Schonheit B (2004) Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging 25, 697-711.
80. Avila J, Gomez de Barreda E, Engel T, Lucas JJ, Hernandez F (2010) Tau phosphorylation in hippocampus results in toxic gain-of-function. Biochem Soc Trans 38, 977-980.
81. LeroyK, Bretteville A, Schindowski K, Gilissen E, Authelet M, De Decker R, Yilmaz Z, Buee L, Brion JP (2007) Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice. Am J Pathol 171, 976-992.
82. Kobayashi Y, Amaral DG (2003) Macaque monkey retrosplenial cortex: II. Cortical afferents. J Comp Neurol 466, 48-79.
83. Kobayashi Y, Amaral DG (2007) Macaque monkey retrosplenial cortex: III. Cortical efferents. J Comp Neurol 502, 810-833.
84. Nieuwenhuys R, Voogd J, van Huijzen C (2008). 12 Telencephalon: Hippocampus and Related Structures. In The Human Central Nervous System 4th edn, Nabbe MM, ed., Vol. 1, Springer, Berlin, pp. 361-400.
85. Çavdar S, Onat FY (2008). In Çakmak YO, Yananli HR, Gülcebi M, Aker R. The pathways connecting the hippocampal formation, the thalamic reuniens nucleus and the thalamic reticular nucleus in the rat. J Anat 212, 249-256.
86. Miller EJ, Saint Marie LR, Breier MR, SwerdlowNR(2010) Pathways from the ventral hippocampus and caudal amygdale to forebrain regions that regulate sensorimotor gating in the rat. Neuroscience 165, 601-611.
87. Braak H, Braak E (1996) Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol 92, 197-201.
88. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, et al. (1993) Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 90, 10962-10966.
89. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C (1993) Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347.
90. Jarrett JT, Lansbury PT Jr. (1993) Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?. Cell 73, 1055-1058.
91. ComeJH, Fraser PE, Lansbury PT Jr. (1993)Akinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci U S A 90, 5959-5963.
92. Huang Z, Prusiner SB, Cohen FE (1996) Structures of prion proteins and conformational models for prion diseases. Curr Top Microbiol Immunol 207, 49-67.
93. von Bergen M, Barghorn S, Biernat J, MandelkowEM,Mandelkow E (2005) Tau aggregation is driven by a transition from random coil to beta sheet structure. Biochim Biophys Acta 1739, 158-166.
94. von Bergen M, Friedhoff P, Biernat J, Heberle J, Mandelkow EM, Mandelkow E (2000) Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. Proc Natl Acad Sci U S A 97, 5129-5134.
95. Wiltzius JJ, Landau M, Nelson R, Sawaya MR, Apostol MI, Goldschmidt L, Soriaga AB, Cascio D, Rajashankar K, Eisenberg D (2009) Molecular mechanisms for proteinencoded inheritance. Nat Struct Mol Biol 16, 973-978.
96. Morrissey MP, Shakhnovich EI (1999) Evidence for the role of PrP(C) helix 1 in the hydrophilic seeding of prion aggregates. Proc Natl Acad Sci U S A 96, 11293-11298.
97. Noinville S, Chich JF, Rezaei H (2008) Misfolding of the prion protein: linking biophysical and biological approaches. Vet Res 39, 48. 48
98. Peretz D, Williamson RA, Kaneko K, Vergara J, Leclerc E, Schmitt-Ulms G, Mehlhorn IR, Legname G, Wormald MR, Rudd PM, Dwek RA, Burton DR, Prusiner SB (2001) Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412, 739-743.
99. Heppner FL, Musahl C, Arrighi I, Klein MA, Rulicke T, Oesch B, Zinkernagel RM, Kalinke U, Aguzzi A (2001) Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 294, 178-182.
100. Speare JO, Rush TS, 3rd, Bloom ME, Caughey B (2003) The role of helix 1 aspartates and salt bridges in the sta bility and conversion of prion protein. J Biol Chem 278, 12522-12529.
101. Gousset K, Schiff E, Langevin C, Marijanovic Z, Caputo A, Browman DT, Chenouard N, de Chaumont F, Martino A, Enninga J, Olivo-Marin J-C, Männel D, Zurzolo C (2009) Prions hijack tunnelling nanotubes for intercellular spread. Nat Cell Biol 11, 328-336.
102. Butowt R, Davies P, Brown DR (2007) Anterograde axonal transport of chicken cellular prion protein (PrPc) in vivo requires its N-terminal part. J Neurosci Res 85, 2567-2579.
103. Saborio GP, Permanne B, Soto C (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810-813.
104. Saa P, Castilla J, Soto C (2006) Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J Biol Chem 281, 35245-35252.
105. Raymond GJ, Bossers A, Raymond LD, O'Rourke KI, McHolland LE, Bryant PK, 3rd, Miller MW, Williams ES, Smits M, Caughey B (2000) Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease. EMBO J 19, 4425-4430.
106. Green KM, Castilla J, Seward TS, Napier DL, Jewell JE, Soto C, Telling GC (2008) Accelerated high fidelity prion amplification within and across prion species barriers. PLoS Pathog 4, e1000139.
107. Wang F, Wang X, Yuan CG, Ma J (2010) Generating a prion with bacterially expressed recombinant prion protein. Science 327, 1132-1135.
108. Uversky VN, Oldfield CJ, Dunker AK (2008) Intrinsically disordered proteins in human diseases: introducing the D2 concept. Annu Rev Biophys 37, 215-246.
109. Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, DeArmond SJ, Prusiner SB (2004) Synthetic mammalian prions. Science 305, 673-676.
110. Colby DW,Wain R, Baskakov IV, Legname G, Palmer CG, Nguyen HO, Lemus A, Cohen FE, DeArmond SJ, Prusiner SB (2010) Protease-sensitive synthetic prions. PLoS Pathog 6, e1000736.
111. Chesebro B (1998) BSE and prions: uncertainties about the agent. Science 279, 42-43.
112. Bartz JC, Bessen RA, McKenzie D, Marsh RF, Aiken JM (2000) Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy. J Virol 74, 5542-5547.
113. Castilla J, Saa P, Hetz C, Soto C (2005) In vitro generation of infectious scrapie prions. Cell 121, 195-206.
114. Deleault NR, Harris BT, Rees JR, Supattapone S (2007) Formation of native prions from minimal components in vitro. Proc Natl Acad Sci U S A 104, 9741-9746.
115. Legname G, Nguyen HO, Baskakov IV, Cohen FE, Dearmond SJ, PrusinerSB(2005) Strain-specified characteristics of mouse synthetic prions. Proc Natl Acad Sci U S A 102, 2168-2173.
116. Legname G, Nguyen HO, Peretz D, Cohen FE, DeArmond SJ, Prusiner SB (2006) Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci U S A 103, 19105-19110.
117. Alonso A, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K (2001) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci U S A 98, 6923-6928.
118. Yonetani M, Nonaka T, Masuda M, Inukai Y, Oikawa T, Hisanaga S, Hasegawa M (2009) Conversion of wild-type alpha-synuclein into mutant-type fibrils and its propagation in the presence of A30P mutant. J Biol Chem 284, 7940-7950.
119. Collinge J, Clarke AR (2007) A general model of prion strains and their pathogenicity. Science 318, 930-936.
120. Ding H, Johnson GV (2008) The last tangle of tau. J Alzheimers Dis 14, 441-447.
121. Gold G, Bouras C,Kovari E, Canuto A, GlariaBG,MalkyA Hof P. R, Michel J. P, & Giannakopoulos, P. (2000) Clinical validity of Braak neuropathological staging in the oldest-old. Acta Neuropathol 99, 579-582; discussion 583-4.
122. Haroutunian V, Schnaider-Beeri M, Schmeidler J, Wysocki M, Purohit DP, Perl DP, Libow LS, Lesser GT, Maroukian M, Grossman HT (2008) Role of the neuropathology of Alzheimer disease in dementia in the oldest-old. Arch Neurol 65, 1211-1217.
123. Hrnkova M, Zilka N, Minichova Z, Koson P, Novak M (2007) Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats. Brain Res 1130, 206-213
124. Race RE, Priola SA, Bessen RA, Ernst D, Dockter J, Rall GF, Mucke L, Chesebro B, Oldstone MB (1995) Neuronspecific expression of a hamster prion protein minigene in transgenic mice induces susceptibility to hamster scrapie agent. Neuron 15, 1183-1191.
125. Prusiner SB, Scott M, Foster D, Pan KM, Groth D, Mirenda C, Torchia M, Yang SL, Serban D, Carlson GA, et al (1990) Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63, 673-686.
126. Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, Collinge J, Doey LJ, Lantos P (1997) The same prion strain causes vCJD and BSE. Nature 389, 448-450, 526.
127. Allen B, Ingram E, Takao M, Smith MJ, Jakes R, Virdee K, Yoshida H, Holzer M, Craxton M, Emson PC, Atzori C, Migheli A, Crowther RA, Ghetti B, Spillantini MG, Goedert M(2002)Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci 22, 9340-9351.
128. Kumar S, Ma B, Tsai CJ, Sinha N, Nussinov R (2000) Folding and binding cascades: dynamic landscapes and population shifts. Protein Sci 9, 10-19.
129. Csermely P, Palotai R, Nussinov R (2010) Induced fit, conformational selection and independent dynamic segments: an extended view of binding events. Trends Biochem Sci 35, 539-546
130. BeringueV,Vilotte JL, LaudeH(2008) Prion agent diversity and species barrier. Vet Res 39, 47.
131. Westaway D, Goodman PA, Mirenda CA, McKinley MP, Carlson GA, Prusiner SB (1987) Distinct prion proteins in short and long scrapie incubation period mice. Cell 51, 651-662.
132. Westaway D, Zuliani V, Cooper CM, Da Costa M, Neuman S, Jenny AL, Detwiler L, Prusiner SB (1994) Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie. Genes Dev 8, 959-969.
133. Spraker TR, Balachandran A, Zhuang D, O'Rourke KI (2004) Variable patterns of distribution of PrP(CWD) in the obex and cranial lymphoid tissues of Rocky Mountain elk (Cervus elaphus nelsoni) with subclinical chronic wasting disease. Vet Res 155, 295-302.
134. Kalinderi K, Fidani L, Bostantjopoulou S (2009) From 1997 to 2007: a decade journey through the H1 haplotype on 17q21 chromosome. Parkinsonism Relat Disord 15, 2-5.
135. Alonso Adel C, Mederlyova A, Novak M, Grundke-Iqbal I, Iqbal K (2004) Promotion of hyperphosphorylation by frontotemporal dementia tau mutations. J Biol Chem 279, 34873-34881.
136. Haase C, Stieler JT, Arendt T, Holzer M (2004) Pseudophosphorylation of tau protein alters its ability for self-aggregation. J Neurochem 88, 1509-1520.
137. Yin H, Kuret J (2006) C-terminal truncation modulates both nucleation and extension phases of tau fibrillization. FEBS Lett 580, 211-215.
138. Govaerts C, Wille H, Prusiner SB, Cohen FE (2004) Evidence for assembly of prions with left-handed beta-helices into trimers. Proc Natl Acad Sci U S A 101, 8342-8347.
139. Stohr J, Weinmann N, Wille H, Kaimann T, Nagel-Steger L, Birkmann E, Panza G, Prusiner SB, Eigen M, Riesner D (2008) Mechanisms of prion protein assembly into amyloid. Proc Natl Acad Sci U S A 105, 2409-2414.
140. DeMarco ML, Daggett V (2004) From conversion to aggregation: protofibril formation of the prion protein. Proc Natl Acad Sci U S A 101, 2293-2298.
141. Cobb NJ, Sonnichsen FD, McHaourab H, Surewicz WK (2007) Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure. Proc Natl Acad Sci U S A 104, 18946-18951.
142. Ruben GC, Novak M, Edwards PC, Iqbal K (2005) Alzheimer paired helical filaments (PHFs) studied by highresolution TEM: What can vertical Pt-C replication tell us about the organization of the pronase-digested PHF core? Microsc Res Techn 67, 196-209.
143. Margittai M (2004) Template-assisted filament growth by parallel stacking of tau. Proc Natl Acad Sci 101, 10278-10283.
144. Skrabana R, Kontsek P, Mederlyova A, Iqbal K, Novak M (2004) Folding of Alzheimer's core PHF subunit revealed by monoclonal antibody 423. FEBS Lett 568, 178-182.
145. Skrabana R, Sevcik J, Novak M (2006) Intrinsically Disordered Proteins in the neurodegenerative processes: formation of tau protein paired helical filaments and their analysis. Cell Mol Neurobiol 26, 1083-1095.
146. Ksiezak-Reding H, Wall JS (2005) Characterization of paired helical filaments by scanning transmission electron microscopy. Microsc Res Techn 67, 126-140.
147. Li L (2002) Structure, stability, and aggregation of paired helical filaments from tau protein and FTDP-17 mutants probed by tryptophan scanning mutagenesis. J Biol Chem 277, 41390-41400.
148. Crowther R (2000) Abnormal tau-containing filaments in neurodegenerative diseases. J Struct Biol 130, 271-279.
149. Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, Terwilliger JD,Westaway D, Ott J, Prusiner SB (1989) Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 338, 342-345.
150. Kitamoto T, Amano N, Terao Y, Nakazato Y, Isshiki T, Mizutani T, Tateishi J (1993) A new inherited prion disease (PrP-P105L mutation) showing spastic paraparesis. Ann Neurol 34, 808-813.
151. Tunnell E, Wollman R, Mallik S, Cortes CJ, Dearmond SJ, Mastrianni JA (2008) A novel PRNP-P105S mutation associated with atypical prion disease and a rare PrPSc conformation. Neurology 71, 1431-1438.
152. Rogaeva E, Zadikoff C, Ponesse J, Schmitt-Ulms G, Kawarai T, Sato C, Salehi-Rad S, St George-Hyslop P, Lang AE (2006) Childhood onset in familial prion disease with a novel mutation in the PRNP gene. Arch Neurol 63, 1016-1021.
153. Rodriguez MM, Peoc'h K, Haik S, Bouchet C, Vernengo L, Manana G, Salamano R, Carrasco L, Lenne M, Beaudry P, Launay JM, Laplanche JL (2005)Anovel mutation (G114V) in the prion protein gene in a family with inherited prion disease. Neurology 64, 1455-1457.
154. Hsiao KK, Cass C, Schellenberg GD, Bird T, Devine-Gage E,Wisniewski H, Prusiner SB (1991)Aprion protein variant in a family with the telencephalic form of Gerstmann- Straussler-Scheinker syndrome. Neurology 41, 681-684.
155. Panegyres PK, Toufexis K, Kakulas BA, Cernevakova L, Brown P, Ghetti B, Piccardo P, Dlouhy SR (2001) A new PRNP mutation (G131V) associated with Gerstmann- Straussler-Scheinker disease. Arch Neurol 58, 1899-1902.
156. Hilton DA, Head MW, Singh VK, Bishop M, Ironside JW (2009) Familial prion disease with a novel serine to isoleucine mutation at codon 132 of prion protein gene (PRNP). Neuropathol Appl Neurobiol 35, 111-115.
157. Kitamoto T, Iizuka R, Tateishi J (1993) An amber mutation of prion protein in Gerstmann-Straussler syndrome with mutant PrP plaques. Biochem Biophys Res Commun 192,525-531.
158. Goldfarb LG, Haltia M, Brown P, Nieto A, Kovanen J, McCombie WR, Trapp S, Gajdusek DC (1991) New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jakob kindred. Lance 337, 425. 425
159. Farlow MR, Yee RD, Dlouhy SR, Conneally PM, Azzarelli B, GhettiB(1989) Gerstmann-Straussler-Scheinker disease. I. Extending the clinical spectrum. Neurology 39, 1446-1452.
160. Kitamoto T, Ohta M, Doh-ura K, Hitoshi S, Terao Y, Tateishi J (1993) Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Straussler syndrome. Biochem Biophys Res Commun 191, 709-714.
161. Nitrini R, Rosemberg S, Passos-Bueno MR, da Silva LS, Iughetti P, Papadopoulos M, Carrilho PM, Caramelli P, Albrecht S, Zatz M, LeBlanc A (1997) Familial spongiform encephalopathy associated with a novel prion protein gene mutation. Ann Neurol 42, 138-146.
162. Butefisch CM, Gambetti P, Cervenakova L, Park KY, Hallett M, Goldfarb LG (2000) Inherited prion encephalopathy associated with the novel PRNP H187R mutation: a clinical study. Neurology 55, 517-522.
163. Roeber S, Grasbon-Frodl EM,Windl O, Krebs B, XiangW, Vollmert C, Illig T, Schroter A, Arzberger T, Weber P, Zerr I, Kretzschmar HA (2008) Evidence for a pathogenic role of different mutations at codon 188 of PRNP. PLoS ONE 3,e2147.
164. Kotta K, Paspaltsis I, Bostantjopoulou S, Latsoudis H, Plaitakis A, Kazis D, Collinge J, Sklaviadis T (2006) Novel mutation of the PRNP gene of a clinical CJD case. BMC Infect Di 6, 169.
165. Goldfarb LG, Mitrova E, Brown P, Toh BK, Gajdusek DC (1990) Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia. Lancet 336, 514-515.
166. Piccardo P, Dlouhy SR, Lievens PM, Young K, Bird TD, Nochlin D, Dickson DW, Vinters HV, Zimmerman TR, Mackenzie IR, Kish SJ, Ang LC, De Carli C, Pocchiari M, Brown P, Gibbs CJ, Gajdusek DC, Bugiani O, Ironside J, Tagliavini F, Ghetti B (1998) Phenotypic variability of Gerstmann-Straussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol 57, 979-988. JJr.
167. Mastrianni JA, Curtis MT, Oberholtzer JC, Da Costa MM, DeArmond S, Prusiner SB, Garbern JY (1995) Prion disease (PrP-A117V) presenting with ataxia instead of dementia. Neurology 45, 2042-2050.
168. Ripoll L, Laplanche JL, Salzmann M, Jouvet A, Planques B, Dussaucy M, Chatelain J, Beaudry P, Launay JM (1993) A new point mutation in the prion protein gene at codon 210 in Creutzfeldt-Jakob disease. Neurology 43, 1934-1938.
169. Ilc G, Giachin G, Jaremko M, Jaremko L, Benetti F, Plavec J, Zhukov I, LegnameG(2010)NMRstructure of the human prion protein with the pathological Q212P mutation reveals unique structural features. PLoS ONE 5, e11715.
170. Hsiao K, Dlouhy SR, Farlow MR, Cass C, Da Costa M, Conneally PM, Hodes ME, Ghetti B, Prusiner SB (1992) Mutant prion proteins in Gerstmann-Straussler- Scheinker disease with neurofibrillary tangles. Nat Genet 1, 68-71.
171. Jansen C, Parchi P, Capellari S, Vermeij AJ, Corrado P, Baas F, Strammiello R, van Gool WA, van Swieten JC, Rozemuller AJ (2010) Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. Acta Neuropathol 119, 189-197.
172. Bratosiewicz J, Barcikowska M, Cervenakowa L, Brown P, Gajdusek DC, Liberski PP (2000) A new point mutation of the PRNP gene in Gerstmann- Straussler-Scheinker case in Poland. Folia Neuropathol 38, 164-166.
173. Hayashi S, Toyoshima Y, Hasegawa M, Umeda Y, Wakabayashi K, Tokiguchi S, Iwatsubo T, Takahashi H (2002) Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation. Ann Neurol 51, 525-530.
174. Poorkaj P, Muma NA, Zhukareva V, Cochran EJ, Shannon KM, Hurtig H, Koller WC, Bird TD, Trojanowski JQ, Lee VM, Schellenberg GD (2002) An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype. Ann Neurol 52, 511-516.
175. Chang E, Kim S, Yin H, Nagaraja HN, Kuret J (2008) Pathogenic missenseMAPTmutations differentially modulate tau aggregation propensity at nucleation and extension steps. J Neurochem 107, 1113-1123.
176. Rizzini C, Goedert M, Hodges JR, Smith MJ, Jakes R, Hills R, Xuereb JH, Crowther RA, Spillantini MG (2000) Tau gene mutation K257T causes a tauopathy similar to Pick's disease. J Neuropathol Exp Neurol 59, 990-1001.
177. Grover A (2003) A novel tau mutation in exon 9 (1260V) causes a four-repeat tauopathy. Exp Neurol 184, 131-140.
178. Kobayashi T, Ota S, Tanaka K, Ito Y, Hasegawa M, Umeda Y, Motoi Y, Takanashi M, Yasuhara M, Anno M, Mizuno Y, Mori H (2003) A novel L266V mutation of the tau gene causes frontotemporal dementia with a unique tau pathology. Ann Neurol 53, 133-137.
179. de Silva R, Lashley T, Strand C, Shiarli AM, Shi J, Tian J, Bailey KL, Davies P, Bigio EH, Arima K, Iseki E, Murayama S, Kretzschmar H, Neumann M, Lippa C, Halliday G, MacKenzie J, Ravid R, Dickson D, Wszolek Z, Iwatsubo T, Pickering-Brown SM, Holton J, Lees A, Revesz T, Mann DM(2006) An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies. Acta Neuropathol 111, 329-340.
180. Spillantini MG, Crowther RA, Kamphorst W, Heutink P, van Swieten JC (1998) Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau. Am J Pathol 153, 1359-1363.
181. Delisle MB, Murrell JR, Richardson R, Trofatter JA, Rascol O, Soulages X, Mohr M, Calvas P, Ghetti B (1999) A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy. Acta Neuropathol 98, 62-77.
182. Iseki E, Matsumura T, Marui W, Hino H, Odawara T, Sugiyama N, Suzuki K, Sawada H, Arai T, Kosaka K (2001) Familial frontotemporal dementia and parkinsonism with a novel N296H mutation in exon 10 of the tau gene and a widespread tau accumulation in the glial cells. Acta Neuropathol 102, 285-292.
183. Yoshida H, Crowther RA, Goedert M (2002) Functional effects of tau gene mutations deltaN296 and N296H. J Neurochem 80, 548-551.
184. Bugiani O, Murrell JR, Giaccone G, Hasegawa M, Ghigo G, Tabaton M, Morbin M, Primavera A, Carella F, Solaro C, Grisoli M, Savoiardo M, Spillantini MG, Tagliavini F, Goedert M, Ghetti B (1999) Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol 58, 667-677.
185. Lladó A, Ezquerra M, Sánchez-Valle R, Rami L, Tolosa E, Molinuevo JL (2007) A novel MAPT mutation (P301T) associated with familial frontotemporal dementia. Eur J Neurol 14, e9-e10.
186. Ros R, Thobois S, Streichenberger N, Kopp N, Sanchez MP, Perez M, Hoenicka J, Avila J, Honnorat J, de Yebenes JG (2005) A new mutation of the tau gene, G303V, in earlyonset familial progressive supranuclear palsy. Arch Neurol 62, 1444-1450.
187. Hasegawa M, Smith MJ, Iijima M, Tabira T, Goedert M (1999) FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10. FEBS Lett 443, 93-96.
188. Rosso SM, Donker Kaat L, Baks T, Joosse M, de Koning I, Pijnenburg Y, de Jong D, Dooijes D, Kamphorst W, Ravid R, Niermeijer MF, Verheij F, Kremer HP, Scheltens P, van Duijn CM, Heutink P, van Swieten JC (2003) Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 126, 2016-2022.
189. van Herpen E, Rosso SM, Serverijnen LA, Yoshida H, Breedveld G, van de Graaf R, Kamphorst W, Ravid R, Willemsen R, Dooijes D, Majoor-Krakauer D, Kros JM, Crowther RA, Goedert M, Heutink P, van Swieten JC (2003) Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R. Ann Neurol 54, 573-581.
190. Zarranz JJ, Ferrer I, Lezcano E, Forcadas MI, Eizaguirre B, Atares B, Puig B, Gomez-Esteban JC, Fernandez-Maiztegui C, Rouco I, Perez-Concha T, Fernandez M, Rodriguez O, Rodriguez-Martinez AB, de Pancorbo MM, Pastor P, Perez- Tur J (2005) A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease. Neurology 64, 1578-1585.
191. Rosso SM, van Herpen E, Deelen W, Kamphorst W, Severijnen LA, Willemsen R, Ravid R, Niermeijer MF, Dooijes D, Smith MJ, Goedert M, Heutink P, van Swieten JC (2002) A novel tau mutation, S320F, causes a tauopathy with inclusions similar to those in Pick's disease. Ann Neurol 51, 373-376.
192. Neumann M, Diekmann S, Bertsch U, Vanmassenhove B, Bogerts B, Kretzschmar HA (2005) Novel G335V mutation in the tau gene associated with early onset familial frontotemporal dementia. Neurogenetics 6, 91-95.
193. Pickering-Brown SM, Baker M, Nonaka T, Ikeda K, Sharma S, Mackenzie J, Simpson SA, Moore JW, Snowden JS, de Silva R, Revesz T, Hasegawa M, Hutton M, Mann DM (2004) Frontotemporal dementia with Pick-type histology associated with Q336R mutation in the tau gene. Brain 127, 1415-1426.
194. Lippa CF, Zhukareva V, Kawarai T, Uryu K, Shafiq M, Nee LE, Grafman J, LiangY, St George-Hyslop PH, Trojanowski JQ, LeeVM(2000) Frontotemporal dementia with novel tau pathology and a Glu342Val tau mutation. Ann Neurol 48, 850-858.
195. Neumann M, Schulz-SchaefferW, Crowther RA, Smith MJ, Spillantini MG, Goedert M, Kretzschmar HA (2001) Pick's disease associated with the novel Tau gene mutation K369I. Ann Neurol 50, 503-513.
196. Liu F, Gong C-X (2008) Tau exon 10 alternative splicing and tauopathies. Mol Neurodegene 3, 8.
197. Nicholl DJ, Greenstone MA, Clarke CE, Rizzu P, Crooks D, Crowe A, Trojanowski JQ, Lee VM, Heutink P (2003) An English kindred with a novel recessive tauopathy and respiratory failure. Ann Neurol 54, 682-686.
198. Murrell JR, Spillantini MG, Zolo P, Guazzelli M, Smith MJ, Hasegawa M, Redi F, Crowther RA, Pietrini P, Ghetti B, Goedert M (1999) Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits. J Neuropathol Exp Neurol 58, 1207-1226.
199. Lindquist SG, Holm IE, Schwartz M, Law I, Stokholm J, Batbayli M, Waldemar G, Nielsen JE (2008) Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation. Eur J Neurol 15, 377-385.
200. D'Souza I, Poorkaj P, Hong M, Nochlin D, Lee VM, Bird TD, Schellenberg GD (1999) Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc Natl Acad Sci U S A 96, 5598-5603.
201. Spillantini MG, Yoshida H, Rizzini C, Lantos PL, Khan N, Rossor MN, Goedert M, Brown J (2000) A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies. Ann Neurol 48, 939-943.
202. Stanford PM, Halliday GM, Brooks WS, Kwok JB, Storey CE, CreaseyH,Morris JG, Fulham MJ, Schofield PR (2000) Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations. Brain 123, 880-893.
203. Momeni P, Pittman A, Lashley T, Vandrovcova J, Malzer E, Luk C, Hulette C, Lees A, Revesz T, Hardy J (2009) Clinical and pathological features of an Alzheimer's disease patient with the MAPTδK280 mutation. Neurobiol Aging 30, 388-393.
204. van Swieten JC, Bronner IF, Azmani A, Severijnen LA, Kamphorst W, Ravid R, Rizzu P, Willemsen R, Heutink P (2007) The DeltaK280 mutation in MAP tau favors exon 10 skipping in vivo. J Neuropathol Exp Neurol 66, 17-25.